State Street Corp Sesen Bio, Inc. Transaction History

State Street Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.54 - $0.65 $360,159 - $433,525	-666,962 Closed	0 $0
Q2 2022 Aug 15, 2022	SELL	$0.38 - $0.89 $1.4 Million - $3.27 Million	-3,672,070 Reduced 84.63%	666,962 $541,000
Q1 2022 May 16, 2022	BUY	$0.58 - $0.86 $30,318 - $44,955	52,274 Added 1.22%	4,339,032 $2.62 Million
Q4 2021 Feb 14, 2022	BUY	$0.73 - $1.28 $200,531 - $351,616	274,700 Added 6.85%	4,286,758 $3.49 Million
Q3 2021 Nov 15, 2021	SELL	$0.77 - $4.91 $7.44 Million - $47.4 Million	-9,663,742 Reduced 70.66%	4,012,058 $3.18 Million
Q2 2021 Aug 16, 2021	BUY	$2.18 - $4.66 $29.6 Million - $63.2 Million	13,558,500 Added 11558.82%	13,675,800 $63.2 Million
Q1 2021 May 17, 2021	BUY	$1.3 - $3.24 $8,840 - $22,032	6,800 Added 6.15%	117,300 $305,000
Q4 2020 Feb 16, 2021	BUY	$1.01 - $1.77 $111,605 - $195,585	110,500 New	110,500 $149,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.